Lutein + Zeaxanthin

Different carotenoids with complementary eye benefits

Comprehensive eye and antioxidant protection

✦ Omega-3

DHA is concentrated in retina; omega-3 improves carotenoid absorption

Enhanced eye health and better lutein uptake

⟡ Bilberry

Different eye-protective mechanisms

Comprehensive eye health support

✦ Meso-Zeaxanthin

All three macular carotenoids work together

Complete macular pigment support

Top studies from 39+ peer-reviewed papers

📚meta-analysisn=387569

Leermakers ET et al. • The American journal of clinical nutrition (2016)

“Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health.”

Key Findings:

Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake.
There was no significant association with type 2 diabetes mellitus (pooled RR: 0.97; 95% CI: 0.77, 1.22), but higher lutein was associated with a lower risk of metabolic syndrome (pooled RR: 0.75; 95% CI: 0.60, 0.92) for the highest compared with the lowest tertile.
Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health.
However, evidence mainly comes from observational studies in adults, whereas large-scale intervention studies and studies of lutein during pregnancy and childhood are scarce.

📚meta-analysis

Choo YM et al. • The Cochrane database of systematic reviews (2025)

“While supplementation with lutein and zeaxanthin from day one of life in preterm infants until discharge probably reduces the incidence of ROP stage 3 and above, it may have little or no effect on the incidence of ROP at any stage, IVH or NEC, or mortality assessed throughout the NICU stay.”

Key Findings:

Lutein and zeaxanthin supplementation probably reduces the incidence of ROP stage 3 and above (RR 0.49, 95% CI 0.29 to 0.81; P = 0.005; I2 = 0%; 4 studies, 532 infants; moderate-certainty evidence).
While supplementation with lutein and zeaxanthin from day one of life in preterm infants until discharge probably reduces the incidence of ROP stage 3 and above, it may have little or no effect on the incidence of ROP at any stage, IVH or NEC, or mortality assessed throughout the NICU stay.
However, the pooled estimates for these outcomes may change with further rigorously conducted trials.
There were no adverse effects reported.

📚systematic-reviewn=2445

Evans JR et al. • The Cochrane database of systematic reviews (2023)

“Moderate-certainty evidence suggests that antioxidant vitamin and mineral supplementation (AREDS: vitamin C, E, beta-carotene, and zinc) probably slows down progression to late AMD.”

Key Findings:

These studies enroled 11,952 people aged 65 to 75 years and included slightly more women (on average 56% women).
People taking antioxidant vitamins were less likely to progress to late AMD (odds ratio (OR) 0.72, 95% confidence interval (CI) 0.58 to 0.90; 3 studies, 2445 participants; moderate-certainty evidence).
Low-certainty evidence from one study of 110 people suggested higher quality of life scores (measured with the Visual Function Questionnaire) in treated compared with non-treated people after 24 months (mean difference (MD) 12.30, 95% CI 4.24 to 20.36).
A similar risk of progression to visual loss of 15 or more letters was seen in the lutein/zeaxanthin and control groups (RR 0.98, 95% CI 0.91 to 1.05; 6656 eyes; low-certainty evidence).

📊rctn=3882

Chew EY et al. • JAMA ophthalmology (2022)

“Results of this long-term epidemiologic follow-up study of the AREDS2 cohort suggest that lutein/zeaxanthin was an appropriate replacement for beta carotene in AREDS2 supplements.”

Key Findings:

This study included 3882 participants (mean [SD] baseline age, 72.0 [7.7] years; 2240 women [57.7%]) and 6351 eyes.
At 10 years, the odds ratio (OR) of having lung cancer was 1.82 (95% CI, 1.06-3.12; P = .02) for those randomly assigned to beta carotene and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.
The hazard ratio (HR) for progression to late AMD comparing lutein/zeaxanthin with no lutein/zeaxanthin was 0.91 (95% CI, 0.84-0.99; P = .02) and comparing ω-3 fatty acids with no ω-3 fatty acids was 1.01 (95% CI, 0.93-1.09; P = .91).
When the lutein/zeaxanthin main effects analysis was restricted to those randomly assigned to beta carotene, the HR was 0.80 (95% CI, 0.68-0.92; P = .002).

📚meta-analysisn=26

Compare with Others Find Based on Your Goals

Hajizadeh-Sharafabad F et al. • Critical reviews in food science and nutrition (2022)

“The overall results supported possible protective effects of carotenoids on inflammatory biomarkers.”

Key Findings:

The random-effect model was used to analyze data and the overall effect size was computed as weighted mean difference (WMD) and corresponding 95% of confidence interval (CI).
A total of 26 trials with 35 effect sizes were included in this meta-analysis.
Also, only lycopene (WMD: ‒1.08 pg/ml, 95%CI: ‒2.03, ‒0.12, P = 0.027) led to a significant decrease in IL-6.

View all 39+ studies

What would you like to do next?

Related Supplements

Pm9.0

Piracetam

9/10

First-ever nootropic (1972) that improves membrane fluidity and AMPA receptor function — decades of safety data for cognitive enhancement.

Mz8.5

Meso-Zeaxanthin

8.5/10

Concentrates in the fovea to shield peak visual acuity from blue light damage — must be supplemented or converted from lutein.

Erg8.0

Ergothioneine

Novel 'longevity vitamin' antioxidant found in mushrooms that accumulates in cells under oxidative stress — emerging longevity compound.

Pqq8.0

PQQ

Unique compound that promotes the growth of new mitochondria, supporting cellular energy and brain health.

Luz9.0

Lutein + Zeaxanthin

compound

Lutein and Zeaxanthin

Carotenoid pigments that accumulate in the eye, providing protection against blue light and age-related vision decline.

longevityeye healthvisionmacularblue light

39+ studies

Evidence

Reviewed 19 days ago

high

Safety

10mg lutein + 2mg zeaxanthin

Dose

12-24 weeks

Time to Effect

Softgels with both lutein and zeaxanthin

Best Form

Mechanisms of Action

🔵

Blue Light Filter

Absorbs harmful blue light before it damages retinal cells

🛡️

Antioxidant Protection

Neutralizes free radicals in the eye

Biological PathwayBeta

How Lutein + Zeaxanthin works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.

Supplement

Molecular Target

Biological Process

Health Outcome

Strong

Moderate

Emerging

strong

moderate

emerging

Tap node to isolate • Pinch to zoom • Tap edge for research

Recommended Dose

10mg lutein + 2mg zeaxanthin

6mg lutein20mg lutein

Optimal Timing

With a meal containing fat

Take with food

Available Forms

Form	Type
💊Softgels with both lutein and zeaxanthin	Recommended
💊FloraGLO lutein (most studied)	Alternative
💊Lutein esters	Alternative

Free-form lutein may absorb better than lutein esters. Look for products with both lutein and zeaxanthin in ~5:1 ratio.

Duration

Minimum: 12 weeks

Optimal: 24 weeks

Cycling: Not required

Note: Fat-soluble carotenoids — absorption improves significantly with dietary fat. Can be taken any time of day.

👁️

Macular Protection

Increases macular pigment optical density

📅 3-6 months

80% of users notice thispositive

💻

Reduced Eye Strain

Less fatigue from screens and bright light

⏱️ 4-8 weeks

65% of users notice thispositive

✨

Better Glare Recovery

Faster recovery from bright light exposure

📅 3-6 months

60% of users notice thispositive

High SafetyMax safe dose: Up to 20mg lutein/day shown safe long-term

🟢

Pregnant/nursing

Safe at recommended doses; found naturally in breast milk

🟢

Smokers

Safe (unlike beta-carotene, no lung cancer concern)

Who Should NOT Take This

Known allergy or hypersensitivity to Lutein + Zeaxanthin or related compounds

Drug Interactions

Beta-carotene supplementsmild

May compete for absorption — take separately

Possible Side Effects

Carotenodermia (yellow skin)

mildrare

Tip: Harmless and reversible; reduce dose

Warnings

Takes months to build up macular pigment — be patient
Not a replacement for regular eye exams

⟡ Astaxanthin

Different carotenoids with complementary eye benefits

Comprehensive eye and antioxidant protection

✦ Omega-3

DHA is concentrated in retina; omega-3 improves carotenoid absorption

Enhanced eye health and better lutein uptake

⟡ Bilberry

Different eye-protective mechanisms

Comprehensive eye health support

✦ Meso-Zeaxanthin

All three macular carotenoids work together

Complete macular pigment support

Top studies from 39+ peer-reviewed papers

📚meta-analysisn=387569

Leermakers ET et al. • The American journal of clinical nutrition (2016)

“Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health.”

Key Findings:

Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake.
There was no significant association with type 2 diabetes mellitus (pooled RR: 0.97; 95% CI: 0.77, 1.22), but higher lutein was associated with a lower risk of metabolic syndrome (pooled RR: 0.75; 95% CI: 0.60, 0.92) for the highest compared with the lowest tertile.
Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health.
However, evidence mainly comes from observational studies in adults, whereas large-scale intervention studies and studies of lutein during pregnancy and childhood are scarce.

📚meta-analysis

Choo YM et al. • The Cochrane database of systematic reviews (2025)

“While supplementation with lutein and zeaxanthin from day one of life in preterm infants until discharge probably reduces the incidence of ROP stage 3 and above, it may have little or no effect on the incidence of ROP at any stage, IVH or NEC, or mortality assessed throughout the NICU stay.”

Key Findings:

Lutein and zeaxanthin supplementation probably reduces the incidence of ROP stage 3 and above (RR 0.49, 95% CI 0.29 to 0.81; P = 0.005; I2 = 0%; 4 studies, 532 infants; moderate-certainty evidence).
While supplementation with lutein and zeaxanthin from day one of life in preterm infants until discharge probably reduces the incidence of ROP stage 3 and above, it may have little or no effect on the incidence of ROP at any stage, IVH or NEC, or mortality assessed throughout the NICU stay.
However, the pooled estimates for these outcomes may change with further rigorously conducted trials.
There were no adverse effects reported.

📚systematic-reviewn=2445

Evans JR et al. • The Cochrane database of systematic reviews (2023)

“Moderate-certainty evidence suggests that antioxidant vitamin and mineral supplementation (AREDS: vitamin C, E, beta-carotene, and zinc) probably slows down progression to late AMD.”

Key Findings:

These studies enroled 11,952 people aged 65 to 75 years and included slightly more women (on average 56% women).
People taking antioxidant vitamins were less likely to progress to late AMD (odds ratio (OR) 0.72, 95% confidence interval (CI) 0.58 to 0.90; 3 studies, 2445 participants; moderate-certainty evidence).
Low-certainty evidence from one study of 110 people suggested higher quality of life scores (measured with the Visual Function Questionnaire) in treated compared with non-treated people after 24 months (mean difference (MD) 12.30, 95% CI 4.24 to 20.36).
A similar risk of progression to visual loss of 15 or more letters was seen in the lutein/zeaxanthin and control groups (RR 0.98, 95% CI 0.91 to 1.05; 6656 eyes; low-certainty evidence).

📊rctn=3882

Chew EY et al. • JAMA ophthalmology (2022)

“Results of this long-term epidemiologic follow-up study of the AREDS2 cohort suggest that lutein/zeaxanthin was an appropriate replacement for beta carotene in AREDS2 supplements.”

Key Findings:

This study included 3882 participants (mean [SD] baseline age, 72.0 [7.7] years; 2240 women [57.7%]) and 6351 eyes.
At 10 years, the odds ratio (OR) of having lung cancer was 1.82 (95% CI, 1.06-3.12; P = .02) for those randomly assigned to beta carotene and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.
The hazard ratio (HR) for progression to late AMD comparing lutein/zeaxanthin with no lutein/zeaxanthin was 0.91 (95% CI, 0.84-0.99; P = .02) and comparing ω-3 fatty acids with no ω-3 fatty acids was 1.01 (95% CI, 0.93-1.09; P = .91).
When the lutein/zeaxanthin main effects analysis was restricted to those randomly assigned to beta carotene, the HR was 0.80 (95% CI, 0.68-0.92; P = .002).

📚meta-analysisn=26

Compare with Others Find Based on Your Goals

Hajizadeh-Sharafabad F et al. • Critical reviews in food science and nutrition (2022)

“The overall results supported possible protective effects of carotenoids on inflammatory biomarkers.”

Key Findings:

The random-effect model was used to analyze data and the overall effect size was computed as weighted mean difference (WMD) and corresponding 95% of confidence interval (CI).
A total of 26 trials with 35 effect sizes were included in this meta-analysis.
Also, only lycopene (WMD: ‒1.08 pg/ml, 95%CI: ‒2.03, ‒0.12, P = 0.027) led to a significant decrease in IL-6.

View all 39+ studies

What would you like to do next?

Related Supplements

Pm9.0

Piracetam

9/10

First-ever nootropic (1972) that improves membrane fluidity and AMPA receptor function — decades of safety data for cognitive enhancement.

Mz8.5

Meso-Zeaxanthin

8.5/10

Concentrates in the fovea to shield peak visual acuity from blue light damage — must be supplemented or converted from lutein.

Erg8.0

Ergothioneine

Novel 'longevity vitamin' antioxidant found in mushrooms that accumulates in cells under oxidative stress — emerging longevity compound.

Pqq8.0

PQQ